From The Stage

CAR T-Cell Therapy: Changing the Way Cancer is Treated

Posted by / / BioAgilytix Insight, Immuno-oncology

One of the most promising types of immunotherapy uses adoptive cell transfer (ACT). While all types of ACT are in their early days of development relatively speaking, one method showing great potential is chimeric antigen receptor T-cell therapy, or CAR-T.

A Dose of Pharma and Biotech News: March 7, 2018

Posted by / / BioAgilytix Insight, Industry Update

BioAgilytix is committed to keeping on the pulse of bioanalytical innovation across the pharmaceutical and biotechnology industries. To that end, we’d like to share some of the industry headlines we’ve been most interested in recently.